Good Manufacturing Practices Guidelines

Introduction

The initial draft of good manufacturing practice (GMP) guidelines by the World Health Organization (WHO) was officially adopted in 1968. Following that, in 1969, the World Health Assembly put forth a recommendation for the inaugural iteration of the WHO certification scheme. This scheme aimed to guarantee the quality of pharmaceutical products worldwide, recognizing the integration of WHO GMP as a fundamental element within the scheme. In 1991, the Expert Committee on Biological Standardization (ECBS) added a supplementary annex focused on biological medicinal products, providing a comprehensive framework for quality control measures concerning vaccines, blood and blood products, antigens, cell and tissue therapies, biopharmaceutical products, and other related items. To date, more than 100 countries have integrated the provisions of WHO GMP into their national legislation governing medicinal products.

Additionally, numerous other countries have adopted the principles and methodology of WHO GMP to formulate their own national GMP requirements. The WHO GMP guidelines continue to serve as the foundation for the WHO Certification Scheme and the prequalification process of vaccines intended for procurement by United Nations (UN) agencies. This article focuses on the GMP guidelines.

What Are Good Manufacturing Practices (GMP)?

GMP stands for goods manufacturing practice that ensures the consistent production and control of products in accordance with the appropriate quality standards, as specified by the marketing authorization. The primary objective of GMP is to mitigate the inherent risks associated with pharmaceutical manufacturing, which can be broadly classified into two categories:

1. Cross-contamination or mix-ups.

2. Incorrect labeling.

The utmost priority is to prevent any compromise in the safety, quality, or effectiveness of products that could jeopardize patient well-being. Consequently, risk assessment has gained significant prominence in the quality assurance guidelines established by the World Health Organization (WHO).

What Are Different Good Manufacturing Practices (GMP) Guidelines?

GMP guidelines are as follows:

1. Building and Facilities:

• Ensure that buildings utilized for manufacturing or storage purposes are adequately sized, designed, and constructed to facilitate unhindered equipment placement, organized material storage, hygienic operations, and efficient cleaning and maintenance.

• Use smooth and easily cleanable surfaces for floors, walls, and ceilings, and keep them in good repair and cleanliness.

• Installing fixtures, ducts, and pipes in a manner that prevents dripping or condensation from contamination of the materials, utensils, equipment surfaces, or finished bulk products.

• Provide sufficient lighting and ventilation that meet the requirements for the intended operations and the comfort of personnel.

• Ensure that the water supply, washing and toilet facilities, floor drainage, and sewage system meet the necessary requirements to maintain sanitary operations, enable effective cleaning of facilities and equipment, and fulfill the personal cleanliness requirements of employees.

2. Equipment:

• Using equipment and utensils with appropriate design, materials, and workmanship to prevent corrosion, material buildup, or contamination with lubricants, dirt, or sanitizing agents during processing, holding, transferring, and filling operations.

• Maintaining and cleaning utensils, transferring piping, and any contact surfaces of equipment regularly, following appropriate sanitation intervals.

• Storing the materials in cleaned and sanitized portable equipment in protected areas to prevent contamination from splashes, dust, or other sources.

3. Personnel:

• Ensure that personnel involved in manufacturing or controlling cosmetics possess the necessary education, training, and experience to perform their assigned functions.

• It is necessary to provide appropriate garments, gloves, hair restraints, etc., for individuals in direct contact with materials or drugs, or finished bulk products to prevent product adulteration and maintain adequate personal cleanliness.

• Restriction of the consumption of food or drink and the use of tobacco in designated areas.

4. Raw Materials:

• Storing and handling the raw materials and primary packaging materials in a manner that prevents mix-up, contamination with microorganisms or chemicals, or deterioration from excessive heat, cold, sunlight, or moisture.

• It is important to close materials containers and store bagged or boxed materials off the floor.

• Label containers of materials with identity or identification numbers and control status information.

• Conducting appropriate sampling and testing or examination of materials to ensure the absence of contamination with filth, microorganisms, or extraneous substances that could adulterate finished products. Special emphasis should be placed on materials derived from animals or plants, as well as those utilized in cold processing methods.

5. Production:

• Establishing manufacturing and controlling procedures, including written instructions for formulations, processing, transferring and filling, and in-process control methods.

• Ensure that processing, transfer, and filling equipment utilized for raw and bulk materials are kept clean, maintained in good condition, and maintained in a sanitary state.

• The use of approved materials during manufacturing is mandatory.

• Try to take samples during or after processing, transfer, or filling for testing to verify adequate mixing, absence of hazardous microorganisms or chemical contaminants, and compliance with acceptance specifications.

• Verify the weighing and measuring of raw materials by a second person and properly identify containers holding materials.

• Clearly identify major equipment, transfer lines, containers, and tanks used in processing, filling, or holding cosmetics to indicate their contents, batch designation, control status, and other relevant information.

• Verify the identity of labels before labeling operations to prevent mix-ups.

• Label equipment used for processing, holding, transferring, and filling batches with information regarding identity, batch identification, and control status.

• Ensure that packages of finished products bear permanent code marks.

6. Laboratory Controls:

• Conduct testing or examination of raw materials, in-process samples, and finished products to validate their identity and adherence to specifications regarding physical and chemical properties, microbial contamination, and undesired chemical contaminants.

• Retain reserve samples of approved batches of raw materials and finished products for the specified time period under appropriate storage conditions.

7. Records:

• Ensure that control records are maintained for raw materials and primary packaging materials, documenting the disposition of rejected materials.

• Maintain records of the manufacturing of batches, documenting the types and quantities of materials used, as well as the processes involved in handling, transferring, holding, and filling.

• Document sampling, controlling, adjusting, and reworking activities related to the manufacturing process.

• Try to keep records of code marks assigned to batches and finished products.

• Document the sampling, individual laboratory controls, test results, and control status of finished products.

• Maintain distribution records, including initial interstate shipment details, code marks, and consignees.

8. Labeling:

• Verify that the labels on the immediate and outer containers contain the necessary information.

• On the principal display panel, include the product name, statements of identity, and net contents.

• In cases where the product's safety has not been sufficiently substantiated, include the statement "Caution - The safety of this product has not been established." Additionally, ascertain the toxicological and/or other testing conducted by the firm to establish product safety.

• On the information panel, provide the name and address of the manufacturing firm or the firm introducing the product into interstate commerce.

• Include a list of ingredients (only on the outer container) if the product is intended for sale.

• Add any other necessary or appropriate warning statements to prevent health hazards based on the identified health hazards or on the basis of the products.

• Provide directions for the safe use of the product.

9. Complaints:

Verify if the firm maintains a consumer complaint file and determine the following information:

• The type and severity of each reported injury, as well as the specific body part that was affected.

• Associate each injury with the respective product, including details such as the manufacturer and code number of the product.

• The medical treatment administered, if any, including the name of the attending physician involved.

• Provide the names and locations of any poison control center, government agency, physician's group, or other relevant entities to whom the material information and/or toxicity data are disclosed.

Conclusion

Adhering to Good Manufacturing Practices (GMP) is crucial for ensuring the consistent production and control of pharmaceutical products. By implementing GMP guidelines, manufacturers can maintain high standards of quality, safety, and efficacy throughout the entire production process. GMP not only mitigates the risks of contamination, mix-ups, and false labeling but also promotes the well-being of patients and the confidence of regulatory authorities. With GMP in place, pharmaceutical companies can provide reliable and effective products that meet the stringent requirements of the industry, ultimately contributing to the overall advancement of healthcare and enhancing patient outcomes.